You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
10 January 2013
Proteo, Inc. / Proteo Biotech AG: FDA grants Proteo Orphan Drug Designation to Elafin for the treatment of pulmonary arterial hypertension
11 December 2012
Proteo, Inc. / Proteo Biotech AG: Update for Phase 2 Study of Elafin in Coronary Bypass Surgery (EMPIRE Study)
27 June 2012
Proteo, Inc. / Proteo Biotech AG: Further rationale for Elafin treatment in newborn infants – convincing preclinical evidence in a neonatal pulmonary model
22 June 2012
6 December 2011
Proteo, Inc./Proteo Biotech AG: Major advances in the elafin development program for lung diseases – NIH supports research on Elafin with a $10.8 million grant
16 August 2011
Proteo, Inc. / Proteo Biotech AG: EMPIRE-Study recruits first coronary bypass patients
9 November 2012
Q3 report 2012
10 August 2012
Q2 report 2012
15 May 2012
Q1 report 2012
28 March 2012
Annual Report 2011
7 November 2011
Q3 report 2011
4 August 2011
Q2 report 2011
